Thermo Fisher Scientific Dirección

Dirección controles de criterios 3/4

El CEO de Thermo Fisher Scientific's es Marc Casper , nombrado en Oct 2009, tiene una permanencia de 14.5 años. compensación anual total es $18.98M, compuesta por 9.1% salario y 90.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.047% de las acciones de la empresa, por valor de $102.40M. La antigüedad media del equipo directivo y de la junta directiva es de 4.4 años y 12.1 años, respectivamente.

Información clave

Marc Casper

Chief Executive Officer (CEO)

US$19.0m

Compensación total

Porcentaje del salario del CEO	9.1%
Permanencia del CEO	14.5yrs
Participación del CEO	0.05%
Permanencia media de la dirección	4.4yrs
Promedio de permanencia en la Junta Directiva	12.1yrs

Actualizaciones recientes de la dirección

Recent updates

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Apr 27

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Apr 24

Thermo Fisher Scientific: Too Hot To Handle

Apr 15

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Apr 02

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Mar 12

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Feb 06

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Jan 16

Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'

Jan 06

Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Dec 29

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Dec 11

Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.

Dec 02

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Jun 07

Buy Thermo Fisher, But With Caution

Jun 01

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Marc Casper en comparación con los beneficios de Thermo Fisher Scientific?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 30 2024	n/a	n/a	US$6b
Dec 31 2023	US$19m	US$2m	US$6b
Sep 30 2023	n/a	n/a	US$6b
Jul 01 2023	n/a	n/a	US$6b
Apr 01 2023	n/a	n/a	US$6b
Dec 31 2022	US$28m	US$2m	US$7b
Oct 01 2022	n/a	n/a	US$7b
Jul 02 2022	n/a	n/a	US$7b
Apr 02 2022	n/a	n/a	US$8b
Dec 31 2021	US$21m	US$2m	US$8b
Oct 02 2021	n/a	n/a	US$9b
Jul 03 2021	n/a	n/a	US$9b
Apr 03 2021	n/a	n/a	US$8b
Dec 31 2020	US$26m	US$2m	US$6b
Sep 26 2020	n/a	n/a	US$5b
Jun 27 2020	n/a	n/a	US$4b
Mar 28 2020	n/a	n/a	US$4b
Dec 31 2019	US$19m	US$2m	US$4b
Sep 28 2019	n/a	n/a	US$4b
Jun 29 2019	n/a	n/a	US$4b
Mar 30 2019	n/a	n/a	US$3b
Dec 31 2018	US$19m	US$1m	US$3b
Sep 29 2018	n/a	n/a	US$3b
Jun 30 2018	n/a	n/a	US$2b
Mar 31 2018	n/a	n/a	US$2b
Dec 31 2017	US$22m	US$1m	US$2b

Compensación vs. Mercado: La compensación total de Marc($USD18.98M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD13.52M).

Compensación vs. Ingresos: La compensación de Marc ha sido consistente con los resultados de la empresa en el último año.

CEO

Marc Casper (55 yo)

14.5yrs

Permanencia

US$18,976,669

Compensación

Mr. Marc N. Casper has been the Chief Executive Officer and President of Thermo Fisher Scientific, Inc. since October 15, 2009 and has been its Chairman of the Board of Directors since February 26, 2020. M...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Marc Casper	Chairman	14.5yrs	US$18.98m	0.047% $ 102.2m
Stephen Williamson	Senior VP & CFO	8.7yrs	US$6.24m	0.010% $ 22.2m
Michel Lagarde	Executive VP & COO	2.3yrs	US$7.25m	0.0026% $ 5.8m
Lisa Britt	Chief Human Resources Officer & Senior VP	7.1yrs	US$2.89m	0.0045% $ 9.9m
Gianluca Pettiti	Executive Vice President	no data	US$5.73m	0.0030% $ 6.6m
Joseph Holmes	VP & Chief Accounting Officer	3.1yrs	sin datos	0.00042% $ 919.6k
Ryan Snyder	Senior VP & Chief Information Officer	4.8yrs	sin datos	sin datos
Karen Nelson	Chief Scientific Officer	2.7yrs	sin datos	sin datos
Rafael Tejada	Vice President of Investor Relations	no data	sin datos	sin datos
Michael Boxer	Senior VP & General Counsel	6.3yrs	US$3.12m	0.0033% $ 7.2m
Sandy Pound	VP & Chief Communications Officer	3.5yrs	sin datos	sin datos
Paul Parker	Senior Vice President of Strategy & Corporate Development	4yrs	sin datos	sin datos

4.4yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TMO se considera experimentado (4.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Marc Casper	Chairman	14.5yrs	US$18.98m	0.047% $ 102.2m
Scott Sperling	Independent Lead Director	17.4yrs	US$403.12k	0.023% $ 51.0m
C. Harris	Independent Director & Member of Scientific Advisory Board	12.1yrs	US$325.72k	0.0020% $ 4.4m
Nelson Chai	Independent Director	13.3yrs	US$365.72k	0.0035% $ 7.8m
Lars Sorensen	Independent Director	7.9yrs	US$345.72k	0.0024% $ 5.1m
Mark Stevenson	Member of Scientific Advisory Board	no data	US$9.40m	sin datos
Tyler Jacks	Member of Scientific Advisory Board & Director	14.9yrs	US$345.72k	0.0020% $ 4.4m
Cynthia Wolberger	Member of Scientific Advisory Board	6.4yrs	sin datos	sin datos
William Hahn	Member of Scientific Advisory Board	no data	sin datos	sin datos
Debora Spar	Independent Director	4.6yrs	US$345.72k	0.00021% $ 459.8k
Steven Gygi	Member of Scientific Advisory Board	no data	sin datos	sin datos
Dion Weisler	Independent Director	7.1yrs	US$353.19k	0.0015% $ 3.4m

12.1yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de TMO son experimentados ( 12.1 años antigüedad media).

Thermo Fisher Scientific Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Senior VP & General Counsel notifies of intention to sell stock

Thermo Fisher Scientific Inc., Annual General Meeting, May 22, 2024

Chairman notifies of intention to sell stock

Chairman notifies of intention to sell stock

Chairman notifies of intention to sell stock

Senior VP & General Counsel notifies of intention to sell stock

Recent updates

Senior VP & General Counsel notifies of intention to sell stock

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Thermo Fisher Scientific: Too Hot To Handle

Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., Annual General Meeting, May 22, 2024

Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature (ULT) Freezers

Thermo Fisher Scientific Inc. to Report Q1, 2024 Results on Apr 24, 2024

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Announces A New In-Line Metrology Solution to Improve Battery Safety and Performance

Chairman notifies of intention to sell stock

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Thermo Fisher Scientific Inc. Launches Corevitas Clinical Registry in Generalized Pustular Psoriasis

Upcoming dividend of US$0.39 per share

Chairman notifies of intention to sell stock

Fourth quarter dividend increased to US$0.39

Thermo Fisher Scientific Inc. Increases Quarterly Cash Dividend, Payable on April 15, 2024

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Inc. Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing

Senior VP & General Counsel notifies of intention to sell stock

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Thermo Fisher Scientific Inc. Announces Earnings Guidance for Full Year 2024

Thermo Fisher Scientific Appoints Srinath Venkatesh as Managing Director, India and South Asia

Thermo Fisher Scientific Receives GMP Approval from the Italian Medicines Agency for its Manufacturing Facility of RNA-Based Products in Monza, Italy

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'

Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Thermo Fisher Scientific Inc. Announces Launch of Innovative Corevitas Pharmacovigilance Platform for Clinical Research Registries

Thermo Fisher Scientific Inc. Announces the Launch of the Thermo Scientific KingFisher Apex Dx and Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Upcoming dividend of US$0.35 per share at 0.3% yield

Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.

Thermo Fisher Scientific Declares Quarterly Dividend, Payable on January 16, 202

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Announces New Fault Localization Solution for the Analysis of Advanced Logic Semiconductors

My Family Is Buying A Lot More Thermo Fisher Stock

Third quarter 2023 earnings: EPS exceeds analyst expectations

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2023

Price target decreased by 7.4% to US$567

Now 24% undervalued after recent price drop

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Thermo Fisher Scientific Inc. to Report Q3, 2023 Results on Oct 25, 2023

Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness

Thermo Fisher Scientific Inc. Appoints Jennifer “Jenny” Johnson to the Audit Committee

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Thermo Fisher Scientific Helps Accelerate Cell Therapy Manufacturing with A Next-Generation Platform of Gibco™ CTS™ Detachable Dynabeads™

Upcoming dividend of US$0.35 per share at 0.3% yield

Executive Vice President notifies of intention to sell stock

Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns

Thermo Fisher Scientific Announces the Launch of the EXENT Solution with IVDR Certification

Thermo Fisher Scientific Introduces New Chromosomal Microarray with Two-Day Turnaround Time to Increase Lab Productivity

Thermo Fisher Scientific Inc. (NYSE:TMO) acquired CorEvitas, LLC from Audax Management Company, LLC for approximately $910 million.

Thermo Fisher: Cash Flow Returns On Investments Analysis

Thermo Fisher Scientific Announces a New Line of Thermo Scientific TM TSG Series Refrigerators

Senior VP & CFO notifies of intention to sell stock

Thermo Fisher Scientific Inc. Revises earnings Guidance for 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research

Thermo Fisher Scientific Inc. Elects Jenny Johnson to Board of Directors

Thermo Fisher Scientific: Continuing To Add To The Fortress

Thermo Fisher Scientific Inc. (NYSE:TMO) has entered into a definitive agreement to acquire CorEvitas, LLC from Audax Management Company, LLC for Approximately $910 million.